Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by component
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Global Market
6.1. Overview
6.2. Market Revenue, by Component (2019–2030)
6.2.1. Data sets Market Revenue, by type (2019–2030)
6.3. Market Revenue, by Application (2019–2030)
6.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
6.4. Market Revenue, by End User (2019–2030)
6.5. Market Revenue, by Region (2019–2030)
Chapter 7. North America Market
7.1. Overview
7.2. Market Revenue, by Component (2019–2030)
7.2.1. Data sets Market Revenue, by type (2019–2030)
7.3. Market Revenue, by Application (2019–2030)
7.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
7.4. Market Revenue, by End User (2019–2030)
7.5. Market Revenue, by Country (2019–2030)
Chapter 8. Europe Market
8.1. Overview
8.2. Market Revenue, by Component (2019–2030)
8.2.1. Data sets Market Revenue, by type (2019–2030)
8.3. Market Revenue, by Application (2019–2030)
8.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
8.4. Market Revenue, by End User (2019–2030)
8.5. Market Revenue, by Country (2019–2030)
Chapter 9. APAC Market
9.1. Overview
9.2. Market Revenue, by Component (2019–2030)
9.2.1. Data sets Market Revenue, by type (2019–2030)
9.3. Market Revenue, by Application (2019–2030)
9.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
9.4. Market Revenue, by End User (2019–2030)
9.5. Market Revenue, by Country (2019–2030)
Chapter 10. LATAM Market
10.1. Overview
10.2. Market Revenue, by Component (2019–2030)
10.2.1. Data sets Market Revenue, by type (2019–2030)
10.3. Market Revenue, by Application (2019–2030)
10.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
10.4. Market Revenue, by End User (2019–2030)
10.5. Market Revenue, by Country (2019–2030)
Chapter 11. MEA Market
11.1. Overview
11.2. Market Revenue, by Component (2019–2030)
11.2.1. Data sets Market Revenue, by type (2019–2030)
11.3. Market Revenue, by Application (2019–2030)
11.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
11.4. Market Revenue, by End User (2019–2030)
11.5. Market Revenue, by Country (2019–2030)
Chapter 12. U.S. Market
12.1. Overview
12.2. Ma Market Revenue, by Component (2019–2030)
12.2.1. Data sets Market Revenue, by type (2019–2030)
12.3. Market Revenue, by Application (2019–2030)
12.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
12.4. Market Revenue, by End User (2019–2030)
12.5. Canada Market
12.6. Overview
12.7. Market Revenue, by Component (2019–2030)
12.7.1. Data sets Market Revenue, by type (2019–2030)
12.8. Market Revenue, by Application (2019–2030)
12.8.1. Drug development and approvals Market Revenue, by type (2019–2030)
12.9. Market Revenue, by End User (2019–2030)
Chapter 13. Germany Market
13.1. Overview
13.2. Market Revenue, by Component (2019–2030)
13.2.1. Data sets Market Revenue, by type (2019–2030)
13.3. Market Revenue, by Application (2019–2030)
13.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
13.4. Market Revenue, by End User (2019–2030)
Chapter 14. France Market
14.1. Overview
14.2. Market Revenue, by Component (2019–2030)
14.2.1. Data sets Market Revenue, by type (2019–2030)
14.3. Market Revenue, by Application (2019–2030)
14.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
14.4. Market Revenue, by End User (2019–2030)
Chapter 15. U.K. Market
15.1. Overview
15.2. Market Revenue, by Component (2019–2030)
15.2.1. Data sets Market Revenue, by type (2019–2030)
15.3. Market Revenue, by Application (2019–2030)
15.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
15.4. Market Revenue, by End User (2019–2030)
Chapter 16. Italy Market
16.1. Overview
16.2. Market Revenue, by Component (2019–2030)
16.2.1. Data sets Market Revenue, by type (2019–2030)
16.3. Market Revenue, by Application (2019–2030)
16.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
16.4. Market Revenue, by End User (2019–2030)
Chapter 17. Spain Market
17.1. Overview
17.2. Market Revenue, by Component (2019–2030)
17.2.1. Data sets Market Revenue, by type (2019–2030)
17.3. Market Revenue, by Application (2019–2030)
17.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
17.4. Market Revenue, by End User (2019–2030)
Chapter 18. Japan Market
18.1. Overview
18.2. Market Revenue, by Component (2019–2030)
18.2.1. Data sets Market Revenue, by type (2019–2030)
18.3. Market Revenue, by Application (2019–2030)
18.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
18.4. Market Revenue, by End User (2019–2030)
Chapter 19. China Market
19.1. Overview
19.2. Market Revenue, by Component (2019–2030)
19.2.1. Data sets Market Revenue, by type (2019–2030)
19.3. Market Revenue, by Application (2019–2030)
19.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
19.4. Market Revenue, by End User (2019–2030)
Chapter 20. India Market
20.1. Overview
20.2. Market Revenue, by Component (2019–2030)
20.2.1. Data sets Market Revenue, by type (2019–2030)
20.3. Market Revenue, by Application (2019–2030)
20.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
20.4. Market Revenue, by End User (2019–2030)
Chapter 21. Australia Market
21.1. Overview
21.2. Market Revenue, by Component (2019–2030)
21.2.1. Data sets Market Revenue, by type (2019–2030)
21.3. Market Revenue, by Application (2019–2030)
21.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
21.4. Market Revenue, by End User (2019–2030)
Chapter 22. South Korea Market
22.1. Overview
22.2. Market Revenue, by Component (2019–2030)
22.2.1. Data sets Market Revenue, by type (2019–2030)
22.3. Market Revenue, by Application (2019–2030)
22.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
22.4. Market Revenue, by End User (2019–2030)
Chapter 23. Brazil Market
23.1. Overview
23.2. Market Revenue, by Component (2019–2030)
23.2.1. Data sets Market Revenue, by type (2019–2030)
23.3. Market Revenue, by Application (2019–2030)
23.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
23.4. Market Revenue, by End User (2019–2030)
Chapter 24. Mexico Market
24.1. Overview
24.2. Market Revenue, by Component (2019–2030)
24.2.1. Data sets Market Revenue, by type (2019–2030)
24.3. Market Revenue, by Application (2019–2030)
24.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
24.4. Market Revenue, by End User (2019–2030)
Chapter 25. Saudi Arabia Market
25.1. Overview
25.2. Market Revenue, by Component (2019–2030)
25.2.1. Data sets Market Revenue, by type (2019–2030)
25.3. Market Revenue, by Application (2019–2030)
25.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
25.4. Market Revenue, by End User (2019–2030)
Chapter 26. South Africa Market
26.1. Overview
26.2. Market Revenue, by Component (2019–2030)
26.2.1. Data sets Market Revenue, by type (2019–2030)
26.3. Market Revenue, by Application (2019–2030)
26.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
26.4. Market Revenue, by End User (2019–2030)
Chapter 27. U.A.E. Market
27.1. Overview
27.2. Market Revenue, by Component (2019–2030)
27.2.1. Data sets Market Revenue, by type (2019–2030)
27.3. Market Revenue, by Application (2019–2030)
27.3.1. Drug development and approvals Market Revenue, by type (2019–2030)
27.4. Market Revenue, by End User (2019–2030)
Chapter 28. Competitive Landscape
28.1. List of Market Players and their Offerings
28.2. Competitive Benchmarking of Key Players
28.3. Product Benchmarking of Key Players
28.4. Recent Strategic Developments
Chapter 29. Company Profiles
29.1. IQVIA Inc.
29.1.1. Business overview
29.1.2. Product and service offerings
29.1.3. Key financial summary
29.2. IBM Corporation
29.2.1. Business overview
29.2.2. Product and service offerings
29.2.3. Key financial summary
29.3. ICON plc
29.3.1. Business overview
29.3.2. Product and service offerings
29.3.3. Key financial summary
29.4. PAREXEL International Corporation
29.4.1. Business overview
29.4.2. Product and service offerings
29.4.3. Key financial summary
29.5. PPD LLC
29.5.1. Business overview
29.5.2. Product and service offerings
29.5.3. Key financial summary
29.6. Optum Inc.
29.6.1. Business overview
29.6.2. Product and service offerings
29.6.3. Key financial summary
29.7. Cognizant Technology Solutions Corporation
29.7.1. Business overview
29.7.2. Product and service offerings
29.7.3. Key financial summary
29.8. Oracle Corporation
29.8.1. Business overview
29.8.2. Product and service offerings
29.8.3. Key financial summary
29.9. SAS Institute Inc.
29.9.1. Business overview
29.9.2. Product and service offerings
29.9.3. Key financial summary
29.10. Syneos Health Inc.
29.10.1. Business overview
29.10.2. Product and service offerings
29.10.3. Key financial summary
Chapter 30. Appendix
30.1. Abbreviations
30.2. Sources and References
30.3. Related Reports
Want a report tailored exactly to your business need?
Request CustomizationWe are Trusted by
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages